Rural Communities Opioid Response Program Implementation
Public Group active %sThe Rural Communities Opioid Response Program (RCORP) is a multi-year opioid focused initiative by the Health Resources and Services Administration (HRSA) aimed at reducing the morbidity and mortality of substance use disorder (SUD), including opioid use disorder (OUD), in rural communities at the highest risk for SUD. RCORP-Implementation will advance Garrett County’s overall goal of reducing OUD by strengthening and expanding SUD/OUD prevention, treatment, and recovery service delivery. By expanding the options for SUD/OUD services across the care spectrum, RCORP-Implementation will help Garrett County residents access treatment and move towards recovery.
Group Admins
Raw Data +
Rural Communities Opioid Response Program Implementation
https://mygarrettcounty.com/groups/rural-communities-opioid-response-program-implementation/
| Measurements | Target Goal | Status | Desired Trend | Contributor | January 2017 | February 2017 | March 2017 | April 2017 | May 2017 | June 2017 | July 2017 | August 2017 | September 2017 | October 2017 | November 2017 | December 2017 | January 2018 | February 2018 | March 2018 | April 2018 | May 2018 | June 2018 | July 2018 | August 2018 | September 2018 | October 2018 | November 2018 | December 2018 | January 2019 | February 2019 | March 2019 | April 2019 | May 2019 | June 2019 | July 2019 | August 2019 | September 2019 | October 2019 | November 2019 | December 2019 | January 2020 | February 2020 | March 2020 | April 2020 | May 2020 | June 2020 | July 2020 | August 2020 | September 2020 | October 2020 | November 2020 | December 2020 | January 2021 | February 2021 | March 2021 | April 2021 | May 2021 | June 2021 | July 2021 | August 2021 | September 2021 | October 2021 | November 2021 | December 2021 | January 2022 | February 2022 | March 2022 | April 2022 | May 2022 | June 2022 | July 2022 | August 2022 | September 2022 | October 2022 | November 2022 | December 2022 | January 2023 | February 2023 | March 2023 | April 2023 | May 2023 | June 2023 | July 2023 | August 2023 | September 2023 | October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | October 2024 | November 2024 | December 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number screened for Substance Use Disorder | Active | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Number of non-fatal overdoses | Active | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Number of fatal opioid overdoes | Active | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Number of healthcare providers who have a DATA waiver | Active | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Number of consortium meetings | Active | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Number with a positive screen for alcohol or substance use | Active | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Number diagnosed with substance abuse disorder | Active | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Number diagnosed with substance use disorder who were also screened for depression | Active | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Number diagnosed with SUD who were also screened for HIV/AIDS/HCV | Active | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Number diagnosed with substance use disorder who were referred to treatment | Active | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Number of duplicated patients who have received MAT | Active | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Number of duplicated patients who have received MAT 3 month w/ no interruption | Active | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Number who received general SUD education or training | Active | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Number of patients with a diagnosis of SUD who were referred to support services | Active | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Incidence of NAS-related births | Active |
Data Narrative
- Screened for SUD/OUD using evidence-based screening tools-CAGE, MAST, DAST, SBIRT, or provider-developing screening questions.
- Non-fatal overdoses from opioid poisoning.
- Fatal overdoses from opioid poisoning; include cases where opioids are the underlying or contributing causes of death; all types (e.g., accidental, unintentional, undetermined.
- Healthcare providers who have a Data Treatment Act 2000 (DATA) waiver.
- Consortium meetings in which the majority of members (>75%) participated
- Screened positive for alcohol, opioid, and other substances
- Diagnosed with alcohol use disorder, opioid use disorder, other substance use disorder.
- Diagnosed with SUD -Screened for clinical depression/substance-induced mental disorders using an age-appropriate standardized tool such as Patient Health Questionnaire 9 (PHQ-9)
- Diagnosed with SUD-tested for HIV/AIDS and Hepatitis C Virus (HCV)
- Diagnosed with SUD-referred for SUD treatment
- Unduplicated patients who received MAT-medication only or with psychosocial therapy
- Unduplicated patients without interruption
- Report providers, paraprofessional staff, and community who participated in direct substance use disorder education or training activities as a result of RCORP funding.
- Diagnosis of SUD who were referred to support service, childcare, employment services, prenatal/postpartum care services, recovery housing, transportation to treatment, other
- Infants born with Neonatal Abstinence Syndrome (NAS)/Neonatal Opioid Withdrawal (NOW) Syndrome-related symptoms
Scaled Data Visualization
Need more visualizations?
Check out the performance management tab to see if this group has additional data analysis options!
Last Modification
Sandy Miller edited this group on October 09, 2019.
Sandy Miller edited this group on October 09, 2019.
Sandy Miller edited this group on October 09, 2019.
Sandy Miller edited this group on October 09, 2019.